LYMPH NODE STAGING IN BIOCHEMOCAL RECURRENT PROSTATE CANCER: DOES THE TRACER MATTERF-18-FLUOROETHYLCHOLINE VERSUS GA-68-PSMA-HBED-CC PET/CT

被引：0
|
作者：
Pfister, David
Porres, Daniel
Steib, Florian
Knuechel, Ruth
Heidenreich, Axel
Behrend, Floroian
Verburg, Frederik
机构：
来源：
JOURNAL OF UROLOGY | 2016年 / 195卷 / 04期
关键词：
D O I：
10.1016/j.juro.2016.02.2005
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP79-07
引用
收藏
页码：E1037 / E1037
页数：1
相关论文
共 50 条
  • [41] Mesorectal Lymph Node Metastases as Index Lesion in 68Ga-PSMA-PET/CT Imaging for Recurrent Prostate Cancer
    Leitsmann, Conrad
    Schmid, Marianne
    Sahlmann, Carsten-Oliver
    Trojan, Lutz
    Strauss, Arne
    FRONTIERS IN SURGERY, 2021, 8
  • [42] Comparative Evaluation of ( 18 F)AlF-PSMA-HBED-CC and 68 Ga-PSMA-HBED-CC in Staging Intermediate-/High-Risk Prostate Cancer: A Prospective Study
    Loureiro, Gerardo Gabriel dos Santos
    Couto, Pablo Duarte
    Gonzalez, Juan Pablo Gambini
    Nunez, Omar Alonso
    WORLD JOURNAL OF NUCLEAR MEDICINE, 2025,
  • [43] PET imaging with of prostate-specific membrane antigen (PSMA) for staging of primary prostate cancer with 68Ga-HBED-PSMA.
    Maurer, Tobias
    Gschwend, Juergen
    Wester, Hans-Juergen
    Souvatzoglou, Michael
    Beer, Ambros
    Holzapfel, Konstantin
    Weirich, Gregor
    Haller, Bernhard
    Kuebler, Hubert
    Schwaiger, Markus
    Eiber, Matthias
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [44] Erratum to: Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients
    Ali Afshar-Oromieh
    Tim Holland-Letz
    Frederik L. Giesel
    Clemens Kratochwil
    Walter Mier
    Sabine Haufe
    Nils Debus
    Matthias Eder
    Michael Eisenhut
    Martin Schäfer
    Oliver Neels
    Markus Hohenfellner
    Klaus Kopka
    Hans-Ulrich Kauczor
    Jürgen Debus
    Uwe Haberkorn
    European Journal of Nuclear Medicine and Molecular Imaging, 2017, 44 : 1781 - 1781
  • [45] 68 Ga-PSMA PET/CT for preoperative lymph nosde staging of high risk prostate cancer
    Schmautz, M.
    Heidenreich, A.
    Pfister, D.
    Hartmann, F.
    EUROPEAN UROLOGY, 2022, 81 : S985 - S985
  • [46] 68GA-PSMA PET/CT FOR PREOPERATIVE LYMPH NOSDE STAGING OF HIGH RISK PROSTATE CANCER
    Schmautz, Maximilian
    Pfister, David
    Hartmann, Florian
    Heidenreich, Axel
    JOURNAL OF UROLOGY, 2022, 207 (05): : E920 - E920
  • [47] Comparison of hybrid 68Ga-PSMA PET/MRI and 68Ga-PSMA PET/CT in the evaluation of lymph node and bone metastases of prostate cancer
    Freitag, Martin T.
    Radtke, Jan P.
    Hadaschik, Boris A.
    Kopp-Schneider, A.
    Eder, Matthias
    Kopka, Klaus
    Haberkorn, Uwe
    Roethke, Matthias
    Schlemmer, Heinz-Peter
    Afshar-Oromieh, Ali
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 (01) : 70 - 83
  • [48] The clinical impact of additional late PET/CT-imaging with 68Ga-PSMA-11 (HBED-CC) in the diagnosis of recurrent prostate cancer
    Afshar-Oromieh, A.
    Sattler, L.
    Kratochwil, C.
    Giesel, F.
    Kopka, K.
    Haberkorn, U.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S166 - S166
  • [49] Comparison of hybrid 68Ga-PSMA PET/MRI and 68Ga-PSMA PET/CT in the evaluation of lymph node and bone metastases of prostate cancer
    Martin T. Freitag
    Jan P. Radtke
    Boris A. Hadaschik
    A. Kopp-Schneider
    Matthias Eder
    Klaus Kopka
    Uwe Haberkorn
    Matthias Roethke
    Heinz-Peter Schlemmer
    Ali Afshar-Oromieh
    European Journal of Nuclear Medicine and Molecular Imaging, 2016, 43 : 70 - 83
  • [50] Biodistribution and radiation dosimetry of 68Ga-PSMA HBED CC—a PSMA specific probe for PET imaging of prostate cancer
    Christian H. Pfob
    Sibylle Ziegler
    Frank Philipp Graner
    Markus Köhner
    Sylvia Schachoff
    Birgit Blechert
    Hans-Jürgen Wester
    Klemens Scheidhauer
    Markus Schwaiger
    Tobias Maurer
    Matthias Eiber
    European Journal of Nuclear Medicine and Molecular Imaging, 2016, 43 : 1962 - 1970
12345